Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Systematic Comparison of the Properties of Clinically Used Angiotensin II Type 1 Receptor Antagonists
Martin C. Michel, Carolyn Foster, Hans R. Brunner, et al.
Pharmacological Reviews (2013) Vol. 65, Iss. 2, pp. 809-848
Closed Access | Times Cited: 271

Showing 1-25 of 271 citing articles:

Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals
Edon Vitaku, David T. Smith, Jón T. Njardarson
Journal of Medicinal Chemistry (2014) Vol. 57, Iss. 24, pp. 10257-10274
Closed Access | Times Cited: 5082
Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels
Vikash P. Chauhan, John D. Martin, Hao Liu, et al.
Nature Communications (2013) Vol. 4, Iss. 1
Open Access | Times Cited: 877
Angiotensin II receptors
Khuraijam Dhanachandra Singh, Sadashiva S. Karnik
Elsevier eBooks (2019), pp. 415-427
Closed Access | Times Cited: 705
International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli
Sadashiva S. Karnik, Hamiyet Ünal, Jacqueline Kemp, et al.
Pharmacological Reviews (2015) Vol. 67, Iss. 4, pp. 754-819
Open Access | Times Cited: 277
Activation of MyD88-dependent TLR1/2 signaling by misfolded α-synuclein, a protein linked to neurodegenerative disorders
Stefano G. Daniele, Dawn Béraud, Connor Davenport, et al.
Science Signaling (2015) Vol. 8, Iss. 376
Open Access | Times Cited: 258
Commonalities in epileptogenic processes from different acute brain insults: Do they translate?
Pavel Klein, Raymond Dingledine, Eleonora Aronica, et al.
Epilepsia (2017) Vol. 59, Iss. 1, pp. 37-66
Open Access | Times Cited: 248
Losartan treatment enhances chemotherapy efficacy and reduces ascites in ovarian cancer models by normalizing the tumor stroma
Yanxia Zhao, Jinghong Cao, Alexander Melamed, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 6, pp. 2210-2219
Open Access | Times Cited: 220
Neuroprotective Effects of Angiotensin Receptor Blockers
Sonia Villapol, Juan M. Saavedra
American Journal of Hypertension (2014) Vol. 28, Iss. 3, pp. 289-299
Open Access | Times Cited: 187
Suzuki–Miyaura cross coupling reaction: recent advancements in catalysis and organic synthesis
Brijesh S. Kadu
Catalysis Science & Technology (2021) Vol. 11, Iss. 4, pp. 1186-1221
Closed Access | Times Cited: 144
Telmisartan for treatment of Covid-19 patients: An open multicenter randomized clinical trial
Mariano Duarte, Facundo Pelorosso, Liliana Nicolosi, et al.
EClinicalMedicine (2021) Vol. 37, pp. 100962-100962
Open Access | Times Cited: 135
The effects of different angiotensin II type 1 receptor blockers on the regulation of the ACE-AngII-AT1 and ACE2-Ang(1–7)-Mas axes in pressure overload-induced cardiac remodeling in male mice
Xingxu Wang, Yong Ye, Hui Gong, et al.
Journal of Molecular and Cellular Cardiology (2016) Vol. 97, pp. 180-190
Closed Access | Times Cited: 148
Novel RAAS agonists and antagonists: clinical applications and controversies
César A. Romero, Marcelo Orías, Matthew R. Weir
Nature Reviews Endocrinology (2015) Vol. 11, Iss. 4, pp. 242-252
Open Access | Times Cited: 136
Angiotensin II type 1 receptor blocker losartan prevents and rescues cerebrovascular, neuropathological and cognitive deficits in an Alzheimer’s disease model
Brice Ongali, Nektaria Nicolakakis, Xin‐Kang Tong, et al.
Neurobiology of Disease (2014) Vol. 68, pp. 126-136
Closed Access | Times Cited: 132
Neurorestoration after traumatic brain injury through angiotensin II receptor blockage
Sonia Villapol, María G. Balarezo, Kwame Ofori Affram, et al.
Brain (2015) Vol. 138, Iss. 11, pp. 3299-3315
Open Access | Times Cited: 124
Drug nanoclusters formed in confined nano-cages of CD-MOF: dramatic enhancement of solubility and bioavailability of azilsartan
Yuanzhi He, Wei Zhang, Tao Guo, et al.
Acta Pharmaceutica Sinica B (2018) Vol. 9, Iss. 1, pp. 97-106
Open Access | Times Cited: 121
Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
Georgia Ragia, Vangelis G. Manolopoulos
European Journal of Clinical Pharmacology (2020) Vol. 76, Iss. 12, pp. 1623-1630
Open Access | Times Cited: 115
Biased Agonism in Drug Discovery—Is It Too Soon to Choose a Path?
Martin C. Michel, Steven J. Charlton
Molecular Pharmacology (2018) Vol. 93, Iss. 4, pp. 259-265
Open Access | Times Cited: 99
The Logic of Carotid Body Connectivity to the Brain
Tymoteusz Żera, Davi J. A. Moraes, Melina P. da Silva, et al.
Physiology (2019) Vol. 34, Iss. 4, pp. 264-282
Closed Access | Times Cited: 94
Telmisartan as tentative angiotensin receptor blocker therapeutic for COVID‐19
Rodolfo Pedro Rothlin, Héctor Vetulli, Mariano Duarte, et al.
Drug Development Research (2020) Vol. 81, Iss. 7, pp. 768-770
Open Access | Times Cited: 81
Bedtime dosing of antihypertensive medications: systematic review and consensus statement: International Society of Hypertension position paper endorsed by World Hypertension League and European Society of Hypertension
George S. Stergiou, Mattias Brunström, Thomas M. MacDonald, et al.
Journal of Hypertension (2022) Vol. 40, Iss. 10, pp. 1847-1858
Open Access | Times Cited: 47
Topical losartan inhibits corneal scarring fibrosis and collagen type IV deposition after Descemet's membrane-endothelial excision in rabbits
Lycia Pedral Sampaio, Guilherme Simões Luz Hilgert, Thomas Michael Shiju, et al.
Experimental Eye Research (2022) Vol. 216, pp. 108940-108940
Open Access | Times Cited: 41
Sex-related similarities and differences in responses to heart failure therapies
Janice Y. Chyou, Hailun Qin, Javed Butler, et al.
Nature Reviews Cardiology (2024) Vol. 21, Iss. 7, pp. 498-516
Closed Access | Times Cited: 14
Angiotensin II type 1 receptor antagonists in animal models of vascular, cardiac, metabolic and renal disease
Martin C. Michel, Hans R. Brunner, Carolyn Foster, et al.
Pharmacology & Therapeutics (2016) Vol. 164, pp. 1-81
Open Access | Times Cited: 73
Novel Anti-fibrotic Therapies
Benita L. McVicker, Robert G. Bennett
Frontiers in Pharmacology (2017) Vol. 8
Open Access | Times Cited: 62
Neuroprotective effect of angiotensin II receptor blockers on the risk of incident Alzheimer’s disease: A nationwide population-based cohort study
Hyun Woo Lee, Seung Yeon Kim, Youngkwon Jo, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 21
Page 1 - Next Page

Scroll to top